skip to content
Primary navigation


Drug - Emsam (transdermal selegiline) Delivering 6 mg in 24 hours, 9 mg in 24 hours, or 12 mg in 24 hours

July 2006

Therapeutic area - Depression


  • Emsam is being used for Major Depressive Disorder AND
  • Patient has failed on at least three other antidepressants due to ineffectiveness or intolerance AND
  • Patient will not concurrently be taking an SSRI, SNRI, tricyclic antidepressant (TCA), Wellbutrin (bupropion), Buspar (buspirone), meperidine, other MAO I’s, or carbamazepine. These drugs are contraindicated for use with Emsam

Brand and generic names of SSRIs and SNRIs

SSRIs and combination drugs
Celexa (citalopram)
Lexapro (escitalopram)
Paxil (paroxetine)
Prozac (fluoxetine)
Symbyax (olanzapine/fluoxetine)
Zoloft (sertraline)

SNRI and others
Cymbalta (duloxetine)
Effexor (venlafaxine)
Wellbutrin (bupropion)
Buspar (buspirone)


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top